Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease

Current Atherosclerosis Reports

Volumn 18, Issue 7, 2016, Pages

  Joris, Peter J ^a   Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular disease; Coronary heart disease; Monounsaturated fatty acids; Oleic acid; Risk markers

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; POLYUNSATURATED FATTY ACID; RAPESEED OIL; SAFFLOWER OIL; SUNFLOWER OIL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

BEEF; CALORIC INTAKE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; ENERGY METABOLISM; FAT INTAKE; FOOD INTAKE; FOOD SOURCE; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); NONHUMAN; NUTRITIONAL PARAMETERS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; THERAPY EFFECT; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIET; RISK FACTOR;

ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIET; ENERGY INTAKE; FATTY ACIDS, MONOUNSATURATED; HUMANS; RISK FACTORS;

EID: 84971643794     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-016-0597-y     Document Type: Review

References (36)

1. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96.
2. Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr. 2009;63:S22–33.
3. Li Y, Hruby A, Bernstein AM, Ley SH, Wang DD, Chiuve SE, et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol. 2015;66:1538–48. This prospective cohort study suggests that replacement of saturated fatty acids for unsaturated fatty acids and/or high-quality carbohydrates reduces CHD risk.
4. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7, e1000252.
5. Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;6, CD011737.
6. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 8th Edition. December 2015. Available at: http://health.gov/dietaryguidelines/2015/guidelines/. Accessed on March 3, 2016.
7. Aranceta J, Perez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. Br J Nutr. 2012;107:S8–22.
8. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;4:1989–2007.
9. Degirolamo C, Rudel LL. Dietary monounsaturated fatty acids appear not to provide cardioprotection. Curr Atheroscler Rep. 2010;12:391–6.
10. O'Neil CE, Keast DR, Fulgoni VL, Nicklas TA. Food sources of energy and nutrients among adults in the US: NHANES 2003–2006. Nutrients. 2012;4:2097–120.
11. Hammad S, Pu S, Jones PJ. Current evidence supporting the link between dietary fatty acids and cardiovascular disease. Lipids. doi:10.1007/s11745-015-4113-x.
12. Gilmore LA, Crouse SF, Carbuhn A, Klooster J, Calles JA, Meade T, et al. Exercise attenuates the increase in plasma monounsaturated fatty acids and high-density lipoprotein cholesterol but not high-density lipoprotein 2b cholesterol caused by high-oleic ground beef in women. Nutr Res. 2013;33:1003–11.
13. Jones PJ, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, Lamarche B, et al. DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am J Clin Nutr. 2014;100:88–97. This well-controlled study shows that oils rich in unsaturated fatty acids with 18 carbon atoms have comparable effects on the serum lipoprotein profile.
14. Jones PJ, MacKay DS, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, et al. High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans. Atherosclerosis. 2015;238:231–8.
15. Melchior JT, Sawyer JK, Kelley KL, Shah R, Wilson MD, Hantgan RR, et al. LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res. 2013;54:2495–503.
16. Kien CL, Bunn JY, Stevens R, Bain J, Ikayeva O, Crain K, et al. Dietary intake of palmitate and oleate has broad impact on systemic and tissue lipid profiles in humans. Am J Clin Nutr. 2014;99:436–45.
17. Kruse M, von Loeffelholz C, Hoffmann D, Pohlmann A, Seltmann AC, Osterhoff M, et al. Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men. Mol Nutr Food Res. 2015;59:507–19.
18. Wien M, Oda K, Sabate J. A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes. Nutr J. 2014;13:10.
19. Vafeiadou K, Weech M, Altowaijri H, Todd S, Yaqoob P, Jackson KG, et al. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Am J Clin Nutr. 2015;102:40–8. This is a large randomized controlled trial reporting that replacement of saturated with unsaturated fats has no impact on vascular function.
20. Labonte ME, Jenkins DJ, Lewis GF, Chiavaroli L, Wong JM, Kendall CW, et al. Adding MUFA to a dietary portfolio of cholesterol-lowering foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia. Br J Nutr. 2013;110:426–36.
21. Sanders TA, Lewis FJ, Goff LM, Chowienczyk PJ, Group RS. SFAs do not impair endothelial function and arterial stiffness. Am J Clin Nutr. 2013;98:677–83. This well-controlled trial shows in a large group of healthy individuals that replacement of saturated fatty acid with cis -monounstatured fatty acid does not affect vascular function.
22. Esser D, van Dijk SJ, Oosterink E, Muller M, Afman LA. A high-fat SFA, MUFA, or n3 PUFA challenge affects the vascular response and initiates an activated state of cellular adherence in lean and obese middle-aged men. J Nutr. 2013;143:843–51.
23. Lithander FE, Herlihy LK, Walsh DM, Burke E, Crowley V, Mahmud A. Postprandial effect of dietary fat quantity and quality on arterial stiffness and wave reflection: a randomised controlled trial. Nutr J. 2013;12:93.
24. Mennella I, Savarese M, Ferracane R, Sacchi R, Vitaglione P. Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans. Food Funct. 2015;6:204–10.
25. Barbour JA, Howe PR, Buckley JD, Wright GC, Bryan J, Coates AM. Lower energy intake following consumption of Hi-oleic and regular peanuts compared with iso-energetic consumption of potato crisps. Appetite. 2014;82:124–30.
26. Duarte Moreira Alves R, Boroni Moreira AP, Silva Macedo V, Brunoro Costa NM, Goncalves Alfenas Rde C, Bressan J. High-oleic peanuts increase diet-induced thermogenesis in overweight and obese men. Nutr Hosp. 2014;29:1024–32.
27. Krishnan S, Cooper JA. Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr. 2014;53:691–710.
28. Clevenger HC, Stevenson JL, Cooper JA. Metabolic responses to dietary fatty acids in obese women. Physiol Behav. 2015;139:73–9.
29. Kien CL, Bunn JY, Tompkins CL, Dumas JA, Crain KI, Ebenstein DB, et al. Substituting dietary monounsaturated fat for saturated fat is associated with increased daily physical activity and resting energy expenditure and with changes in mood. Am J Clin Nutr. 2013;97:689–97. In this article, Kien and colleagues demonstrate that substituting monounsaturated fat for saturated fat is associated with an increased resting energy expenditure.
30. Gillingham LG, Harris-Janz S, Jones PJ. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids. 2011;46:209–28.
31. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90. The PREDIMED study is the first large randomized controlled trial showing the benefit of a Mediterranean diet pattern on CVD risk.
32. Rose GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart disease. Br Med J. 1965;1:1531–3.
33. Guasch-Ferre M, Babio N, Martinez-Gonzalez MA, Corella D, Ros E, Martin-Pelaez S, et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Am J Clin Nutr. 2015;102:1563–73. This recently published prospective cohort study found that intakes of monounsaturated fatty acids are associated with a lower risk of CVD and death.
34. Simila ME, Kontto JP, Mannisto S, Valsta LM, Virtamo J. Glycaemic index, carbohydrate substitution for fat and risk of CHD in men. Br J Nutr. 2013;110:1704–11. Within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a prospective cohort study in male smokers, replacements of carbohydrates for cis-MUFA reduced the risk of CHD.
35. Campmans-Kuijpers MJ, Sluijs I, Nothlings U, Freisling H, Overvad K, Boeing H, et al. The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr. 2015. doi:10.1016/j.clnu.2015.08.003. In patients with type 2 diabetes, substitution of carbohydrates with MUFAs may be associated with lower CVD mortality.
36. Praagman J, Beulens JW, Alssema M, Zock PL, Wanders AJ, Sluijs I, et al. The association between dietary saturated fatty acids and ischemic heart disease depends on the type and source of fatty acid in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Am J Clin Nutr. 2016;103:356–65. Replacement of saturated fatty acids for other macronutrients was associated with a lower risk of CHD in this Dutch cohort from the European Prospective Investigation into Cancer and Nutrition.